Quick Answer
Pharmagreen Biotech Inc. reported Research And Development Expense of $4.0 thousand for the year ending 2019.
- Pharmagreen Biotech Inc. showed a decrease of -48.1% in Research And Development Expense from 2018 to 2019.
- This data is from Pharmagreen Biotech Inc.'s annual report (Form 10-K), filed with the SEC on January 8, 2021.
- XBRL data for this metric is available from 2018 to 2019 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2019: $4.0 thousand | Fiscal year 2018: $7.6 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: